[Treatment of idiopathic pulmonary fibrosis]

Rev Mal Respir. 2006 Apr;23(2 Pt 2):5S87-5S91.
[Article in French]
No abstract available

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use*
  • Age Factors
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Antioxidants / therapeutic use
  • Azathioprine / administration & dosage
  • Azathioprine / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use
  • Disease Progression
  • Drug Combinations
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Lung Transplantation
  • Prednisone / administration & dosage
  • Prednisone / therapeutic use
  • Pulmonary Fibrosis / drug therapy*
  • Pulmonary Fibrosis / physiopathology
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Antioxidants
  • Drug Combinations
  • Glucocorticoids
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Azathioprine
  • Prednisone